Table 1.
Patient and experimental overview
| Patient group | N | N female | Age range (mean; median) | Collection site |
|---|---|---|---|---|
| Stage 1 | ||||
| Neuropathic pain (NP1) | 14 | 11 | 46–68 (56; 55) | Uppsala, Sweden |
| Minor urology surgery (C1) | 95 | 4 | 21–81 (60; 65) | Cluj, Romania |
| Stage 2 | ||||
| Neuropathic pain (NP2) | 11 | 6 | 39–65 (55; 57) | Linköping, Sweden |
| Healthy controls (C2) | 11 | 6 | 44–57 (52; 54) | Linköping, Sweden |
| Minor urology surgery (C3) | 28 | 9 | 21–89 (51; 55) | Cluj, Romania |
| Fibromyalgia (FM) | 40 | 40 | 25–61 (47; 48) | Oslo, Norway |
| Total | 199 | 76 (38%) |
Notes: Summary of all sample sets included in this study. C1 and C3 control samples were from the same patient population but were divided into two groups for inclusion in both experimental stages.